UBS Group AG - ALTERITY THERAPEUTICS LTD ownership

ALTERITY THERAPEUTICS LTD's ticker is ATHE and the CUSIP is 02155X106. A total of 14 filers reported holding ALTERITY THERAPEUTICS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ALTERITY THERAPEUTICS LTD
ValueSharesWeighting
Q1 2022$9,000
-10.0%
10,487
-22.9%
0.00%
Q4 2021$10,000
+66.7%
13,599
+191.9%
0.00%
Q2 2021$6,0004,658
+6554.3%
0.00%
Q1 2021$0
-100.0%
70
-96.3%
0.00%
Q4 2020$3,0001,915
+704.6%
0.00%
Q3 2020$0
-100.0%
238
-99.6%
0.00%
Q2 2020$63,000
+3050.0%
53,114
+1626.2%
0.00%
Q1 2020$2,0003,077
+4295.7%
0.00%
Q4 2019$0
-100.0%
70
-97.0%
0.00%
Q3 2019$3,000
-62.5%
2,352
-62.9%
0.00%
Q2 2019$8,0006,3390.00%
Other shareholders
ALTERITY THERAPEUTICS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 19,590$16,0000.00%
TCWP LLC 7,750$6,0000.00%
UBS Group AG 10,487$9,0000.00%
Sugarloaf Wealth Management, LLC 333$00.00%
OSAIC HOLDINGS, INC. 375$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 12,128$9,0000.00%
MORGAN STANLEY 579,964$481,0000.00%
ENVESTNET ASSET MANAGEMENT INC 82,386$67,0000.00%
Citadel Advisors 23,576$19,0000.00%
View complete list of ALTERITY THERAPEUTICS LTD shareholders